CD24 expression has a prognostic impact in breast carcinoma

被引:43
作者
Athanassiadou, Pauline [1 ]
Grapsa, Dimitra [1 ]
Gonidi, Maria [1 ]
Athanassiadou, Anna-Maria [1 ]
Tsipis, Angelos [1 ]
Patsouris, Efstratios [1 ]
机构
[1] Univ Athens, Sch Med, Dept Pathol 1, Cytol Unit, GR-11527 Athens, Greece
关键词
Apoptosis; BAG-1; Breast; Carcinoma; CD24; APOPTOTIC PROTEIN BAG-1; P-SELECTIN; CELL CARCINOMAS; TUMOR-MARKER; IN-SITU; CANCER; SURVIVAL; DIFFERENTIATION; IDENTIFICATION; ANTIGEN;
D O I
10.1016/j.prp.2009.01.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We investigated the prognostic significance of BAG-1 and CD24 in invasive breast carcinomas. Seventy cases of invasive breast carcinoma were studied immunocytochemically for the expression of BAG-1 and CD24. The results were correlated with several prognostic parameters, including 5-year survival. Univariate analysis showed a significant correlation of BAG-1 and CD24 overall positive staining with several adverse prognostic parameters, such as increased stage (p<0.0001), tumor grade 3 (p = 0.016 and p = 0.02, respectively), positive lymph nodes (p<0.0001), and increased tumor size (p<0.0001). Similar results were found for BAG-1 nuclear staining, as well as for positive cytoplasmic CD24 expression. Both of our markers studied had a significant, negative effect on survival. Multivariate analysis further revealed an independent prognostic impact for CD24 overall staining. The results of our study showed that overall cytoplasmic and especially nuclear BAG-1 expression, as well as overall and cytoplasmic CD24 expression, correlates with adverse prognostic parameters. An independent prognostic value for overall CD24 staining was also demonstrated. (C) 2009 Elsevier GmBH. All rights reserved.
引用
收藏
页码:524 / 533
页数:10
相关论文
共 44 条
[31]   CD24 promotes invasion of glioma cells in vivo [J].
Senner, V ;
Sturm, A ;
Baur, I ;
Schrell, UHM ;
Distel, L ;
Paulus, W .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (08) :795-802
[32]  
Siziopikou KP, 1996, CANCER, V77, P499, DOI 10.1002/(SICI)1097-0142(19960201)77:3<499::AID-CNCR11>3.0.CO
[33]  
2-#
[34]   CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma [J].
Su, MC ;
Hsu, C ;
Kao, HL ;
Jeng, YM .
CANCER LETTERS, 2006, 235 (01) :34-39
[35]  
Surowiak P, 2006, ANTICANCER RES, V26, P629
[36]   BAG-1 modulates the chaperone activity of Hsp70/Hsc70 [J].
Takayama, S ;
Bimston, DN ;
Matsuzawa, S ;
Freeman, BC ;
AimeSempe, C ;
Xie, ZH ;
Morimoto, RI ;
Reed, JC .
EMBO JOURNAL, 1997, 16 (16) :4887-4896
[37]  
Takayama S, 1998, CANCER RES, V58, P3116
[38]   CLONING AND FUNCTIONAL-ANALYSIS OF BAG-1 - A NOVEL BCL-2-BINDING PROTEIN WITH ANTI-CELL DEATH ACTIVITY [J].
TAKAYAMA, S ;
SATO, T ;
KRAJEWSKI, S ;
KOCHEL, K ;
IRIE, S ;
MILLAN, JA ;
REED, JC .
CELL, 1995, 80 (02) :279-284
[39]   BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma [J].
Tang, SC ;
Beck, J ;
Murphy, S ;
Chernenko, G ;
Robb, D ;
Watson, P ;
Khalifa, M .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 84 (03) :203-213
[40]   Expression of BAG-1 in invasive breast carcinomas [J].
Tang, SC ;
Shaheta, N ;
Chernenko, G ;
Khalifa, M ;
Wang, XK .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1710-1719